Hepatitis News and Research

RSS

Yale researchers create "humanized" liver in living mice to study chronic liver diseases

Yale researchers have created a functional "humanized" liver in living mice that will help scientists find human-specific mechanisms for regulating cholesterol levels and potentially for treating chronic liver diseases afflicting tens of millions of people in the United States.

9 Aug 2023

Sugar-sweetened beverages linked to increased risk of liver cancer and chronic liver disease mortality

Approximately 65% of adults in the United States consume sugar sweetened beverages daily. Chronic liver disease is a major cause of morbidity and mortality worldwide and can result in liver cancer and liver disease-related mortality.

8 Aug 2023

Identification of plasma proteins associated with ovarian cancer risk

Researchers performed proteomic Mendelian randomization as well as co-localization analyses to identify drug targets for ovarian cancer.

8 Aug 2023

Hepatitis C treatment initiation found to be low among Medicaid recipients

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University's Ithaca campus.

8 Aug 2023

Researchers uncover genetic machinery responsible for EBV-induced B cell growth transformation

B cells or B lymphocytes are an important part of the body's immune system. When healthy B cells are infected with the Epstein-Barr virus (EBV), they undergo growth transformation, a process that immortalizes B cells, leading to their uncontrolled proliferation.

7 Aug 2023

Penn State researchers develop new method for creating cyclopropanes

Chemical structures called cyclopropanes can increase the potency and fine-tune the properties of many drugs, but traditional methods to create this structure only work with certain molecules and require highly reactive-;potentially explosive-;ingredients. Now, a team of researchers from Penn State has identified and demonstrated a safe, efficient and practical way to create cyclopropanes on a wide variety of molecules using a previously undescribed chemical process.

4 Aug 2023

CDC report highlights the gaps in care of hepatitis C treatment

The prevalence of hepatitis C virus clearance was only 34% overall and even lower in individuals between 20 and 39 years of age.

3 Aug 2023

Hepatitis C cure still linked to higher mortality rates

Individuals who have been cured of hepatitis C infection still face a substantially greater risk of death compared with the general population - between 3 and 14 times higher depending on liver disease stage, finds the largest study of its kind published by The BMJ today.

2 Aug 2023

What are the mediators linking cardiometabolic risk factors and severe COVID-19?

Researchers performed a genome-wide association study to explore whether biomarker levels are causally related to COVID-19 hospitalization.

2 Aug 2023

Antiviral protein protects against COVID-19 in live mouse models

A mammalian protein previously shown by UT Southwestern microbiologists to inhibit the virus that causes COVID-19 in cell culture also protected live mouse models, significantly limiting infection in the lung cells and diminishing the symptoms.

1 Aug 2023

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

A recent study published in Frontiers in Medicine described anti-post-translational modification (PTM) antibodies in patients with autoimmune-mediated and cholestatic liver diseases (AILD).

31 Jul 2023

Climate change-driven extreme weather events impacting HIV control in Asia Pacific

Climate change-driven extreme weather events, sea level rise, changes in temperature, and air and water pollution are impacting control of HIV in the Asia Pacific region, a science gathering heard.

28 Jul 2023

Recent progress in infant hepatitis B vaccination efforts in Africa

Researchers report advancements made toward the elimination of mother-to-child transmission of hepatitis B infection.

27 Jul 2023

Study highlights advantages of syphilis self-testing: convenience, privacy, and rapid results

Researchers performed a meta-analysis on the utility of syphilis self-testing (SST).

26 Jul 2023

The effect of dietary supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccine

Researchers discuss the effects of supplements on antibody levels following immunization against SARS-CoV-2 with inactivated vaccines.

21 Jul 2023

Study identifies potential immune biomarker for pulmonary tuberculosis: a step towards early detection

Researchers have identified a potential immune biomarker associated with pulmonary TB in active patients compared to controls.

19 Jul 2023

AI and infection control: preventing infectious disease outbreaks and pandemics

Researchers discussed the role of artificial intelligence (AI) in preventing outbreaks of infectious diseases and future pandemics.

19 Jul 2023

Immunodiagnosis: Unleashing the potential of personalized immunotherapy

Researchers discuss the concept of immunodiagnosis and explores the potential of artificial intelligence in ID systems for precise tumor immunotherapy.

18 Jul 2023

Washington University surgeons pioneer robotic liver transplantation

A surgical team from Washington University School of Medicine in St. Louis recently performed the first robotic liver transplant in the U.S. in May at Barnes-Jewish Hospital.

12 Jul 2023

Alcohol-related hepatitis hospitalizations increased dramatically during the pandemic

A boom in alcohol sales during the pandemic appears to have had dire consequences for some as hospital admissions for alcohol-related hepatitis, a life-threatening liver inflammation, increased dramatically, according to a study of national hospitalization data.

10 Jul 2023

Hepatitis News and Research

Yale researchers create "humanized" liver in living mice to study chronic liver diseases

Sugar-sweetened beverages linked to increased risk of liver cancer and chronic liver disease mortality

Identification of plasma proteins associated with ovarian cancer risk

Hepatitis C treatment initiation found to be low among Medicaid recipients

Researchers uncover genetic machinery responsible for EBV-induced B cell growth transformation

Penn State researchers develop new method for creating cyclopropanes

CDC report highlights the gaps in care of hepatitis C treatment

Hepatitis C cure still linked to higher mortality rates

What are the mediators linking cardiometabolic risk factors and severe COVID-19?

Antiviral protein protects against COVID-19 in live mouse models

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

Climate change-driven extreme weather events impacting HIV control in Asia Pacific

Recent progress in infant hepatitis B vaccination efforts in Africa

Study highlights advantages of syphilis self-testing: convenience, privacy, and rapid results

The effect of dietary supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccine

Study identifies potential immune biomarker for pulmonary tuberculosis: a step towards early detection

AI and infection control: preventing infectious disease outbreaks and pandemics

Immunodiagnosis: Unleashing the potential of personalized immunotherapy

Washington University surgeons pioneer robotic liver transplantation

Alcohol-related hepatitis hospitalizations increased dramatically during the pandemic

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News